This study investigates the treatment of IgG4-related disease in adults using an investigational medication compared to a placebo. The study will last up to 60 weeks, including a 4 to 6-week screening period, a 52-week treatment period, and 2 weeks of follow-up. Participants will be in the study for the …
This study investigates warm autoimmune hemolytic anemia (wAIHA). Participants will be in the study for up to 24 weeks in the primary analysis period, followed by 28 weeks in an open-label period, and potentially up to 52 weeks in a long-term extension, depending on response. The purpose is to evaluate …
This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma. The purpose is to evaluate the safety and effectiveness of this add-on therapy in participants who are not eligible for biologic treatments. Participants will be involved in the study for about 64 …
This study investigates airway inflammation in people aged 40 to 85 years with Chronic Obstructive Pulmonary Disease (COPD). The purpose of this study is to compare the effects of an investigational medication with a placebo on lung function and quality of life.Participants will receive either the investigational medication or a …
This study investigates the effectiveness and safety of an investigational medication compared to the usual treatment of intravenous immunoglobulin (IVIg) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). Participants will be in the study for up to 25 months, which is about 2 years.During the study, participants will receive either …
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP). The study aims to evaluate the effectiveness and safety of an investigational medication compared to a placebo in adults with CIDP who do not respond to usual treatments. Participants will be involved in the study for up to 25 months, which is …
This study investigates the effects of an investigational medication on Type 1 diabetes. The purpose of the study is to compare the investigational medication with a placebo in adults and adolescents who are also receiving insulin therapy. Participants will be involved in the study for up to 135 weeks.Study procedures …
This study investigates the effectiveness and safety of an investigational medication compared to a placebo for treating chronic lung allograft dysfunction (CLAD) in adults. Participants will have already undergone a bilateral lung transplant and will be receiving a standard treatment regimen including azithromycin and immunosuppression therapies.Participants in the study will …
This study investigates chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of the study is to evaluate how effective and safe an investigational medication is when used with nasal sprays in adults with CRSwNP. Participants will be in the study for up to 76 weeks, which includes time for screening, …
This study investigates the safety and efficacy of an investigational medication in adults with microscopic colitis who are in clinical remission. This study involves participants who have a confirmed diagnosis of this condition and are currently receiving budesonide therapy.Participants in the study will be randomly assigned to receive either the …
